This study is a prospective, randomized, controlled multicenter clinical study. The aim of the study is to investigate whether the combination of maintenance hemodialysis (MHD) with hemoperfusion (HP) could improve the clearance rate of middle and large molecule uremic toxins so as to improve the quality of life of MHD patients and reduce their mortality rate.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
440
Chinese PLA General Hospital
Beijing, Beijing Municipality, China
Clearance rate of uremic toxins
Time frame: 0,3,6,12 months
Evaluation of quality of life
Time frame: 0,3,6,12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.